Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ethiqa XR
- Development stage
- Unknown
- Lead developer
- Fidelis Animal Health
- Modality
- Small Molecules
- Administration
- Subcutaneous
01
Overview
Ethiqa XR is a veterinary **extended-release buprenorphine injectable suspension** developed by Fidelis Animal Health for control of post-procedural pain in laboratory and captive animal species including rodents, ferrets, rabbits, and non-human primates. The active ingredient is buprenorphine hydrochloride, a small-molecule opioid analgesic formulated using Fidelis Animal Health's long-acting lipid-based delivery technology to provide sustained analgesia for up to 72 hours after a **single subcutaneous injection**. Pharmacologically, buprenorphine acts primarily as a **partial agonist at the mu-opioid receptor**, producing analgesia through modulation of opioid signaling. Ethiqa XR is an FDA-indexed veterinary product and a Schedule III controlled substance.
- Brand names
- Ethiqa XR
- Other names
- buprenorphine extended-release injectable suspension
02
Targets
DOR (Opioid Receptor Delta 1)KOR (Kappa opioid receptor)MOR (Mu opioid receptor)
Beyond the preview
Go deeper on Ethiqa XR.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ethiqa XR.